ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
Survival prediction of
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeOur study aims to investigate the predictive potential of FDG PET/CT in pediatric patients with NB at the time of recurrence.
methodsPediatric patients with suspected recurrence of NB underwent FDG PET/CT were included in this retrospective study. The clinicopathological data, PET visual analysis data and semiquantitative values (maximum standardized uptake value (SUVmax) of tumor, tumor-to-liver uptake ratio (TLR), metabolic tumor volume (MTV), total lesion glycolysis (TLG)), were analyzed. The Kaplan-Meier curves and Cox proportional hazard models were applied in the evaluation of the independent prognostic significance of FDG PET/CT.
resultsA total of 45 NB patients who underwent FDG PET/CT due to suspected recurrence of NB and got later confirmation of recurrence clinically or pathologically were included in this retrospective study. Among the PET/CT parameters, recurrent primary site TLR cutoff at 5.64 and SUVmax cutoff at 4.10 derived from the receiver operating characteristic curve yielded significant difference (TLR HR = 2.692, p = 0.014; SUVmax HR = 7.698, 0.045) in overall survival (OS). Besides, INSS stage 4, the time from diagnosis to first relapse (TTFR) and recurrence interval were related with shorter survival time in the four established multivariate Cox regression models.
conclusionFDG PET/CT showed great survival predictable performance in recurrent NB. SUVmax, TLR, INSS stage 4, TTFR and recurrence interval were independent risk factors for overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.